{"id":"W2606176026","doi":"10.1200/jco.2012.30.15_suppl.7029","title":"Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma (MPM).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pemetrexed; Medicine; Cisplatin; Mesothelioma; Internal medicine; Clinical endpoint; Carboplatin; Progression-free survival; Chemotherapy; Phases of clinical research; Oncology; Randomized controlled trial; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001235889,0.001821102,0.002248773,0.0004318009,0.0004219571,0.0009886916,0.0008926925,0.00160896,0.009763866],"category_scores_gemma":[0.001136189,0.0007905267,0.0009408968,0.0003832782,0.001117286,0.000928725,0.0004561361,0.002916158,0.001762011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009554124,"about_ca_system_score_gemma":0.001539656,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001347534,"about_ca_topic_score_gemma":0.003118644,"domain_scores_codex":[0.9996344,0.0001957678,0.00001616977,0.00006653819,0.00002403574,0.00006299992],"domain_scores_gemma":[0.9994399,0.0001114106,0.00008886623,0.00005107356,0.00002715493,0.0002815907],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9600652,0.01104143,0.0007954852,0.0005074009,0.000441728,0.0001012836,0.00005626519,0.0007069634,0.006306323,0.0001921472,0.001950697,0.01783509],"study_design_scores_gemma":[0.9450305,0.05191408,0.001207278,0.00001738547,0.0001459625,0.00004308863,0.00001331638,0.0003557719,0.000336468,0.0001328063,0.0007946922,0.000008584431],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741712,0.003413568,0.0008316569,0.001683887,0.0008397587,0.01134171,0.002676814,0.0002184818,0.004822872],"genre_scores_gemma":[0.9747149,0.002114533,0.001730307,0.002353646,0.0004074564,0.009857371,0.002538285,0.00003986138,0.006243579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009763866,"threshold_uncertainty_score":0.0326634,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07018429908058689,"score_gpt":0.4454287572877507,"score_spread":0.3752444582071638,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}